Alkem Of India Recalls Batches Of Ampicillin Injectables
This article was originally published in PharmAsia News
India's Alkem announced it was recalling six batches of ampicillin injections from foreign markets, particularly in France and Africa. The recall followed a retesting of the drug ordered after reports last October that the drug as delivered did not contain the specified dosage. France's AFFSAPS tested the drugs and, along with other European laboratories, reported the failures. Alkem said the drug continues to pass U.S. standards, but decided to recall the drug. (Click here for more
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.